Please check your internet connection and try again.
# Lorazepam (a representative benzodiazepine)
## Overview
Lorazepam is a benzodiazepine medication commonly used for its sedative, anxiolytic, anticonvulsant, and muscle relaxant properties.
## Primary Indications
* Anxiety disorders
* Insomnia
* Seizure management (e.g., status epilepticus)
* Premedication for surgical procedures
* Management of agitation and delirium
## Adult Dosing
* **Anxiety:** 0.5 mg to 2 mg orally every 6 to 8 hours. Maximum recommended daily dose is typically 10 mg.
* **Insomnia:** 2 mg to 4 mg orally at bedtime.
* **Premedication:** 2 mg to 4 mg orally 1 to 2 hours before surgery, or 0.05 mg/kg (max 4 mg) IM or IV 15 to 20 minutes before surgery.
* **Status Epilepticus:** 4 mg slow IV push. If seizures persist after 5-10 minutes, a second 4 mg dose may be administered. IM dose is 10 mg (preferred in settings where IV access is difficult).
*Note: Dosing for acute agitation or specific procedural sedation may vary based on institutional protocols and patient response.*
## Pediatric Dosing
Dosing in pediatric patients is highly variable and requires careful consideration of age, weight, and clinical indication. There is no universally established pediatric dosing guideline for many indications.
* **Status Epilepticus:** Recommended doses range from 0.05 mg/kg to 0.1 mg/kg IV/IM, not to exceed 4 mg per dose.
* **Anxiety/Sedation:** Dosing is not well-established and is typically individualized.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution; reduced doses may be necessary.
* **Renal Impairment:** No specific dose adjustment is routinely recommended, but caution is advised.
## Contraindications
* Known hypersensitivity to benzodiazepines or any component of the formulation.
* Acute narrow-angle glaucoma.
* Severe respiratory insufficiency.
## Adverse Effects
Common adverse effects include drowsiness, dizziness, weakness, and unsteadiness. Less common but serious effects include anterograde amnesia, paradoxical reactions (e.g., excitement, aggression), respiratory depression (especially with IV administration or when combined with other CNS depressants), and dependence with prolonged use.
## Key Drug Interactions
* **CNS Depressants (e.g., opioids, alcohol, sedatives, antipsychotics):** Additive CNS depression, increasing the risk of sedation, respiratory depression, and coma.
* **CYP3A4 Inhibitors/Inducers:** While lorazepam is primarily metabolized by glucuronidation, other benzodiazepines can be affected by CYP3A4. Potential for altered metabolism and effects.
* **Theophylline/Aminophylline:** May reduce the sedative effects of lorazepam.
## Monitoring
* Level of consciousness and sedation.
* Respiratory rate and oxygen saturation, especially with parenteral administration or in patients with underlying respiratory conditions.
* Signs of paradoxical reactions.
* Signs of dependence or withdrawal if used long-term.
## Clinical Pearls
* Lorazepam has a relatively intermediate half-life compared to other benzodiazepines.
* It is often preferred for IV administration in status epilepticus due to its potential for IM absorption and slower onset of action compared to midazolam, which can allow for better titration and less overshoot.
* Avoid abrupt discontinuation after prolonged use due to the risk of withdrawal symptoms. Tapering is recommended.
* Use with caution in the elderly due to increased sensitivity to sedative effects and risk of falls.
---
***Disclaimer:** This information is intended for clinical professionals and does not replace comprehensive prescribing information. Always consult the official product monograph and current clinical guidelines for definitive dosing, indications, and safety information.*
